Tag Archives: The New York Times

Poems: Robert Frost’s “The Road Not Taken” As Drawn By Sergio Garcia Sanchez

Sergio García Sánchez is a cartoonist, illustrator and professor at the University of Granada, as well as co-author of the graphic novel “Lost in NYC: A Subway Adventure.”

Visualizing Robert Frost’s Seminal Poem
The illustrator Sergio Garcia Sanchez embarks on the road not taken.

Read more

Classical Music – Flute: “Dance of the Blessed Spirits” – Christoph Gluck

5 Minutes That Will Make You Love the Flute

It’s an instrument based on the most fundamental sign of life: breath. Listen to the best music ever written for it.

The flute is one of humanity’s oldest ways of producing a beautiful sound, and it is based on the most fundamental sign of life: breath. Made from bones, wood or reeds, the earliest specimens date from the Paleolithic era. The flute is often associated with things elegiac, poetic, angelic — with purity — but also with the world of magic; in mythology, Orpheus seduces the underworld playing the flute. In this excerpt from Gluck’s Orpheus opera, the flute is extremely sensual, and, with its lyrical soaring, takes us from earthly pleasures to heavenly ones.

Flute: Julien Beaudiment

Piano: Hugh Sung

Read article

Retirement: Medicare, Medigap & Part D – Seniors Find Choices “Dizzying”

If you’re enrolled only in original Medicare with a Medigap supplemental plan, and don’t use a drug plan, there’s no need to re-evaluate your coverage, experts say. But Part D drug plans should be reviewed annually. The same applies to Advantage plans, which often wrap in prescription coverage and can make changes to their rosters of in-network health care providers.

“The amount of information that consumers need to grasp is dizzying, and it turns them off from doing a search,” Mr. Riccardi said. “They feel paralyzed about making a choice, and some just don’t think there is a more affordable plan out there for them.”

November 13, 2020

When creation of the prescription drug benefit was being debated, progressive Medicare advocates fought to expand the existing program to include drug coverage, funded by a standard premium, similar to the structure of Part B. The standard Part B premium this year is $144.60; the only exceptions to that are high-income enrollees, who pay special income-related surcharges, and very low-income enrollees, who are eligible for special subsidies to help them meet Medicare costs.

“Given the enormous Medicare population that could be negotiated for, I think most drugs could be offered through a standard Medicare plan,” said Judith A. Stein, executive director of the Center for Medicare Advocacy.

“Instead, we have this very fragmented system that assumes very savvy, active consumers will somehow shop among dozens of plan options to see what drugs are available and at what cost with all the myriad co-pays and cost-sharing options,” she added.

Advocates like Ms. Stein also urged controlling program costs by allowing Medicare to negotiate drug prices with pharmaceutical companies — something the legislation that created Part D forbids.

Read full article in NY Times